Welcome Back |Sign in | Register
Your Position: Home > Inhibitors/Agonists > NU6027

View History

NU6027
prev zoom next

Name:NU6027

  • Catalog No.:
  • BCM004910
  • CAS No.:
  • 220036-08-8
  • Formula:
  • C11H17N5O2
  • Molecular:
  • 251.28
  • Chem Name:
  • 6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine
  • Synonym:
  • NU6027
  • Storage:
  • Inert atmosphere. Store in freezer, under -20°C
  • MDL No.:
  • MFCD05664735
  • Form:
  • Reddish-purple powder
  • Wish  | Compare  | Referral bonuses
SKU Specification Brand Prices Stock Quantity Cart
BCM004910-10MG 10mg, Purity:98% BCM $125 3 Add Cart
BCM004910-25MG 25mg, Purity:98% BCM $55 2 Add Cart
BCM004910-50MG 50mg, Purity:98% BCM $85 1 Add Cart
For more quantities, please contact telephone:0755-85269922,Or send an email to:sales@biochemmall.com

Product Description

Attribute

Goods Tag

Related Products

 

NU6027 is a potent ATR/CDK inhibitor that inhibits CDK1/2, ATR, and DNA-PK with Ki of 2.5 μM/1.3 μM, 0.4 μM, and 2.2 μM, respectively, and enters cells more easily than 6-aminopurine inhibitors.

 

Brand: BCM

 

Target: CDK1:2.5 μM(Ki), ATR:0.4 μM(Ki), DNA-PK:2.2 μM(Ki), CDK2:1.3 μM(Ki)

 

Signaling Pathways: Cell Cycle/Checkpoint; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling

 

Melting Point: 252.5-253.7 °C(lit.)

 

Boiling Point: 549.2±60.0 °C(Predicted)

 

pKa: 2.52±0.10(Predicted)

 

Solubility: Soluble in DMSO; soluble in Ethanol. Insoluble in Water.


Isomeric SMILES: C1CCC(CC1)COC2=NC(=NC(=C2N=O)N)N  

 

InChIKey: DGWXOLHKVGDQLN-UHFFFAOYSA-N  

 

InChI: InChI=1S/C11H17N5O2/c12-9-8(16-17)10(15-11(13)14-9)18-6-7-4-2-1-3-5-7/h7H,1-6H2,(H4,12,13,14,15)

 

Attribute
[CAS No.] 220036-08-8
[Formula] C11H17N5O2
[Molecular] 251.28
[Chem Name] 6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine
[Synonym] NU6027
[Storage] Inert atmosphere. Store in freezer, under -20°C
[MDL No.] MFCD05664735
[Form] Reddish-purple powder

Goods Tag

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages. First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha